StepStone Group Leads $80m Series C in AcuityMD’s AI-Driven Medtech Platform
StepStone Group led an $80m Series C financing in AcuityMD, bringing total funding to over $160m to boost AI augmentation in its medtech sales platform. The new capital will support launch of AcuityAI, deepen the medtech data ontology and extend the platform across the full product lifecycle.
1. Investment Details
StepStone Group spearheaded an $80m Series C funding round for AcuityMD, with participation from Benchmark, Redpoint Ventures, ICONIQ and Atreides Management, lifting the company’s total financing to more than $160m.
2. Platform Reach and AI Plans
AcuityMD’s platform, used by 16 of the top 20 medtech firms, aggregates physician, facility, procedure and reimbursement metrics alongside clients’ internal data; the latest funds will underwrite the launch of AcuityAI to deliver contextual insights to sales reps.
3. Strategic Implications for StepStone Group
The deal enhances StepStone’s exposure to AI-driven healthcare solutions, diversifying its private equity portfolio and positioning it to capitalize on growth in medtech commercial analytics.
4. Future Outlook
With funding earmarked for deepening its data ontology and expanding beyond commercial launches into full product lifecycle adoption, AcuityMD aims to scale its platform across global healthcare markets, potentially boosting returns for early investors.